DV
Dividend Vision

ORGO — Organogenesis Holdings Inc

Organogenesis Holdings Inc (ORGO)

Total return is -81.6% over the past 9.6 years, 379.8 points behind SPY at 298.2%. Its deepest 1-year drawdown was 73.1%.

ORGO is an equity fund that provides exposure to Organogenesis Holdings Inc, a single-stock holding focused on the regenerative medicine and advanced wound care sector. The fund does not currently pay distributions, making it unsuitable for income-focused strategies. This holding appeals primarily to investors seeking targeted exposure to the regenerative medicine industry rather than those prioritizing dividend income.

ORGO key facts

Asset type
Stock
Asset class
Equity
Inception date
01/05/2017
Last close
$1.79
Market cap
$338,414,080
Average volume
547600.0
Beta
1.329
Payout ratio
0.0
Forward P/E
12.6743
EPS
$-0.12